This fall, Fierce Pharma Marketing launched a running series of Q&A features celebrating up-and-comers in our corner of the ...

When Ali Sullivan enrolled at Indiana University, she thought she wanted to become a speech pathologist. Midway through her ...

AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was USD 3.76 billion in 2023, increased to USD 3.95 billion in 2024, ...

Glenmark Pharmaceuticals announced that the U.S. Food and Drug Administration (USFDA) has successfully concluded its pre-approval inspection at the company's formulations manufacturing facility in ...

Indianapolis-based Eli Lilly is the first publicly traded U.S. healthcare company to reach market capitalization over $1 trillion, elevating the drugmaker to an exclusive list dominated by tech giants ...

AstraZeneca and Sun Pharma will jointly market SZC, a key hyperkalaemia drug for CKD and heart failure patients, under ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

In the not too distant past, pharma lagged behind consumer advertising’s ability to churn out cutting-edge creativity. Weighed down by the regulatory, safety and compliance aspects that are par for ...

Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

Despite the broader market strength, Laurus Labs appears to be under pressure as CITI has maintained its ‘Sell’ rating with a target price of Rs 590. With the stock currently around Rs 1,030, the ...

Of the 34 listed companies in the sector, 23 have so far disclosed their first-quarter results. Fourteen of these firms posted year-on-year profit growth, six reported declines, while three slipped ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has ...